Postoperative and Long-Term Endocrinologic Complications of Craniopharyngioma

https://doi.org/10.1038/s41572-019-0125-9

2.

Müller

HL

,

Merchant

TE

,

Warmuth-Metz

M

,

Martinez-Barbera

J-P

,

Puget

S

.

Craniopharyngioma

.

Nat Rev Dis Primers

.

2019

;

5

(

1

):

1

–

19

.

.

https://doi.org/10.1093/neuonc/not026

3.

Cohen

M

,

Bartels

U

,

Branson

H

,

Kulkarni

AV

,

Hamilton

J

.

Trends in treatment and outcomes of pediatric craniopharyngioma, 1975–2011

.

Neuro-oncology

.

2013

;

15

(

6

):

767

–

74

.

.

https://doi.org/10.3171/2018.6.JNS18901

4.

Ordóñez-Rubiano

EG

,

Forbes

JA

,

Morgenstern

PF

,

Arko

L

,

Dobri

GA

,

Greenfield

JP

, et al.

Preserve or sacrifice the stalk? Endocrinological outcomes, extent of resection, and recurrence rates following endoscopic endonasal resection of craniopharyngiomas

.

J Neurosurg

.

2018

;

1

:

1

–

9

.

.

https://doi.org/10.3171/2019.4.PEDS18612

5.

Madsen

PJ

,

Buch

VP

,

Douglas

JE

,

Parasher

AK

,

Lerner

DK

,

Alexander

E

, et al.

Endoscopic endonasal resection versus open surgery for pediatric craniopharyngioma: comparison of outcomes and complications

.

J Neurosurg Pediatr

.

2019

;

7

:

1

–

10

.

.

https://doi.org/10.1007/s00381-019-04168-2

6.

d'Avella

E

,

Solari

D

,

Somma

T

,

Miccoli

G

,

Milicevic

M

,

Cappabianca

P

, et al.

The endoscopic endonasal approach for pediatric craniopharyngiomas: the key lessons learned

.

Childs Nerv Syst

.

2019 Nov

;

35

(

11

):

2147

–

55

.

.

https://doi.org/10.1016/j.wneu.2019.06.037

7.

Apra

C

,

Enachescu

C

,

Lapras

V

,

Raverot

G

,

Jouanneau

E

.

Is gross total resection reasonable in adults with craniopharyngiomas with hypothalamic involvement?

World Neurosurg

.

2019 Sep

;

129

:

e803

–

11

.

.

https://doi.org/10.1016/j.clon.2018.01.012

8.

Ajithkumar

T

,

Mazhari

AL

,

Stickan-Verfürth

M

,

Kramer

PH

,

Fuentes

CS

,

Lambert

J

, et al.

Proton therapy for craniopharyngioma: an early report from a single European centre

.

Clin Oncol

.

2018

;

30

(

5

):

307

–

16

.

.

https://doi.org/10.1159/000120856

9.

Sklar

CA

.

Craniopharyngioma: endocrine abnormalities at presentation

.

Pediatr Neurosurg

.

1994

;

21

(

Suppl 1

):

18

–

20

.

.

https://doi.org/10.4183/aeb.2018.549

10.

Capatina

C

,

Vintila

M

,

Gherlan

I

,

Dumitraşcu

A

,

Caragheorgheopol

A

,

Procopiuc

C

, et al.

Craniopharyngioma: clinical and therapeutic outcome data in a mixed cohort of adult and paediatric cases

.

Acta Endocrinol

.

2018 Oct–Dec

;

14

(

4

):

549

–

55

.

.

https://doi.org/10.1111/j.1365-2265.1995.tb02664.x

11.

Paja

M

,

Lucas

T

,

García-Uría

J

,

Salamé

F

,

Barceló

B

,

Estrada

J

.

Hypothalamic-pituitary dysfunction in patients with craniopharyngioma

.

Clin Endocrinol

.

1995

;

42

(

5

):

467

–

73

.

.

https://doi.org/10.1210/clinem/dgz043

12.

Mende

KC

,

Kellner

T

,

Petersenn

S

,

Honegger

J

,

Evangelista-Zamora

R

,

Droste

M

, et al.

Clinical situation, therapy, and follow-up of adult craniopharyngioma

.

J Clin Endocrinol Metab

.

2020

;

105

(

1

):

dgz043

.

.

https://doi.org/10.1159/000120873

13.

Sklar

CA

.

Craniopharyngioma: endocrine sequelae of treatment

.

Pediatr Neurosurg

.

1994

;

21

(

Suppl 1

):

120

–

3

.

.

https://doi.org/10.1007/s00381-013-2041-8

14.

Pratheesh

R

,

Swallow

DM

,

Rajaratnam

S

,

Jacob

KS

,

Chacko

G

,

Joseph

M

, et al.

Incidence, predictors and early post-operative course of diabetes insipidus in paediatric craniopharygioma: a comparison with adults

.

Childs Nerv Syst

.

2013

;

29

(

6

):

941

–

9

.

.

https://doi.org/10.1001/archpedi.1989.02150140095027

15.

McDonald

JA

,

Martha

PM

,

Kerrigan

J

,

Clarke

WL

,

Rogol

AD

,

Blizzard

RM

.

Treatment of the young child with postoperative central diabetes insipidus

.

Am J Dis Child

.

1989

;

143

(

2

):

201

–

4

.

.

https://doi.org/10.1007/s003810050224

16.

Lehrnbecher

T

,

Müller-Scholden

J

,

Danhauser-Leistner

I

,

Sörensen

N

,

von Stockhausen

HB

.

Perioperative fluid and electrolyte management in children undergoing surgery for craniopharyngioma. A 10-year experience in a single institution

.

Childs Nerv Syst

.

1998

;

14

(

6

):

276

–

9

.

.

https://doi.org/10.4103/2152-7806.136399

17.

Mukherjee

KK

,

Dutta

P

,

Singh

A

,

Gupta

P

,

Srinivasan

A

,

Bhagat

H

, et al.

Choice of fluid therapy in patients of craniopharyngioma in the perioperative period: a hospital-based preliminary study

.

Surg Neurol Int

.

2014

;

5

:

105

–

11

.

.

https://doi.org/10.1159/000324115

18.

Finken

MJ

,

Zwaveling-Soonawala

N

,

Walenkamp

MJ

,

Vulsma

T

,

van Trotsenburg

AS

,

Rotteveel

J

.

Frequent occurrence of the triphasic response (diabetes insipidus/hyponatremia/diabetes insipidus) after surgery for craniopharyngioma in childhood

.

Horm Res Paediatr

.

2011

;

76

(

1

):

22

–

6

.

.

https://doi.org/10.1542/pir.2016-0165

19.

Jones

DP

.

Syndrome of inappropriate secretion of antidiuretic hormone and hyponatremia

.

Pediatr Rev

.

2018

;

39

(

1

):

27

–

35

.

.

https://doi.org/10.1016/S0140-6736(05)62563-9

20.

Hanna

FW

,

Scanlon

MF

.

Hyponatraemia, hypothyroidism, and role of arginine-vasopressin

.

Lancet

.

1997

;

350

(

9080

):

755

–

6

.

.

https://doi.org/10.1007/s11102-011-0294-3

21.

Sinha

A

,

Ball

S

,

Jenkins

A

,

Hale

J

,

Cheetham

T

.

Objective assessment of thirst recovery in patients with adipsic diabetes insipidus

.

Pituitary

.

2011

;

14

(

4

):

307

–

11

.

.

https://doi.org/10.1210/js.2018-00406

22.

Pabich

S

,

Flynn

M

,

Pelley

E

.

Daily sodium monitoring and fluid intake protocol: preventing recurrent hospitalization in adipsic diabetes insipidus

.

J Endocr Soc

.

2019

;

3

(

5

):

882

–

6

.

.

https://doi.org/10.1016/0002-9343(67)90096-4

23.

Bartter

FC

,

Schwartz

WB

.

The syndrome of inappropriate secretion of antidiuretic hormone

.

Am J Med

.

1967

;

42

(

5

):

790

–

806

.

.

https://doi.org/10.1152/ajpregu.1994.267.6.R1617

24.

Verbalis

JG

.

Pathogenesis of hyponatremia in an experimental model of the syndrome of inappropriate antidiuresis

.

Am J Physiol

.

1994

;

267

(

6 Pt 2

):

R1617

.

.

https://doi.org/10.1016/j.amjmed.2015.11.005

25.

Verbalis

JG

,

Greenberg

A

,

Burst

V

,

Haymann

JP

,

Johannsson

G

,

Peri

A

, et al.

Diagnosing and treating the syndrome of inappropriate antidiuretic hormone secretion

.

Am J Med

.

2016

;

129

(

5

):

537

.

.

https://doi.org/10.1097/PEC.0b013e31827b54c3

26.

Brenkert

TE

,

Estrada

CM

,

McMorrow

SP

,

Abramo

TJ

.

Intravenous hypertonic saline use in the pediatric emergency department

.

Pediatr Emerg Care

.

2013 Jan

;

29

(

1

):

71

–

3

.

.

https://doi.org/10.1172/JCI115292

27.

Lien

YH

,

Shapiro

JI

,

Chan

L

.

Study of brain electrolytes and organic osmolytes during correction of chronic hyponatremia. Implications for the pathogenesis of central pontine myelinolysis

.

J Clin Invest

.

1991

;

88

(

1

):

303

–

9

.

.

https://doi.org/10.1016/j.amjmed.2007.09.001

28.

Verbalis

JG

,

Goldsmith

SR

,

Greenberg

A

,

Schrier

RW

,

Sterns

RH

.

Hyponatremia treatment guidelines 2007: expert panel recommendations

.

Am J Med

.

2007

;

120

(

11 Suppl 1

):

S1

–

21

.

.

https://doi.org/10.2215/CJN.04020318

29.

Rondon-Berrios

H

,

Tandukar

S

,

Mor

MK

,

Ray

EC

,

Bender

FH

,

Kleyman

TR

, et al.

Urea for the treatment of hyponatremia

.

Clin J Am Soc Nephrol

.

2018

;

13

(

11

):

1627

–

32

.

.

https://doi.org/10.1002/jcph.342

30.

Chen

S

,

Zhao

JJ

,

Tong

NW

,

Guo

XH

,

Qiu

MC

,

Yang

GY

, et al.

Randomized, double blinded, placebo-controlled trial to evaluate the efficacy and safety of tolvaptan in Chinese patients with hyponatremia caused by SIADH

.

J Clin Pharmacol

.

2014

;

54

(

12

):

1362

–

7

.

.

https://doi.org/10.1111/cen.12943

31.

Tzoulis

P

,

Waung

JA

,

Bagkeris

E

,

Carr

H

,

Khoo

B

,

Cohen

M

, et al.

Real-life experience of tolvaptan use in the treatment of severe hyponatraemia due to syndrome of inappropriate antidiuretic hormone secretion

.

Clin Endocrinol

.

2016

;

84

(

4

):

620

–

6

.

.

https://doi.org/10.4274/jcrpe.galenos.2018.2018.0182

32.

Gürbüz

F

,

Taştan

M

,

Turan

İ

,

Yüksel

B

.

Efficiency of single dose of tolvaptan treatment during the triphasic episode after surgery for craniopharyngioma

.

J Clin Res Pediatr Endocrinol

.

2019

;

11

(

2

):

202

–

6

.

.

https://doi.org/10.1007/s40264-015-0327-3

33.

Watkins

PB

,

Lewis

JH

,

Kaplowitz

N

,

Alpers

DH

,

Blais

JD

,

Smotzer

DM

, et al.

Clinical pattern of tolvaptan-associated liver injury in subjects with autosomal dominant polycystic kidney disease: analysis of clinical trials database

.

Drug Saf

.

2015

;

38

(

11

):

1103

–

13

.

.

https://doi.org/10.1016/s1043-2760(03)00048-1

34.

Palmer

BF

.

Hyponatremia in patients with central nervous system disease: SIADH versus CSW

.

Trends Endocrinol Metab

.

2003

;

14

(

4

):

182

–

7

.

.

https://doi.org/10.1016/s0140-6736(96)08093-2

35.

Berendes

E

,

Walter

M

,

Cullen

P

,

Prien

T

,

Van Aken

H

,

Horsthemke

J

, et al.

Secretion of brain natriuretic peptide in patients with aneurysmal subarachnoid haemorrhage

.

Lancet

.

1997

;

349

(

9047

):

245

.

.

https://doi.org/10.1007/BF03343981

36.

Filippella

M

,

Cappabianca

P

,

Cavallo

LM

,

Faggiano

A

,

Lombardi

G

,

de

DE

, et al.

Very delayed hyponatremia after surgery and radiotherapy for a pituitary macroadenoma

.

J Endocrinol Invest

.

2002

;

25

(

2

):

163

–

8

.

.

https://doi.org/10.1097/01.CCM.0000034676.11528.E4

37.

Singh

S

,

Bohn

D

,

Carlotti

AP

,

Cusimano

M

,

Rutka

JT

,

Halperin

ML

.

Cerebral salt wasting: truths, fallacies, theories, and challenges

.

Crit Care Med

.

2002

;

30

(

11

):

2575

–

9

.

.

https://doi.org/10.1681/ASN.2007101118

38.

Sterns

RH

,

Silver

SM

.

Cerebral salt wasting versus SIADH: what difference?

J Am Soc Nephrol

.

2008

;

19

(

2

):

194

–

6

.

.

https://doi.org/10.1001/archinternmed.2007.126

39.

Lee

P

,

Jones

GR

,

Center

JR

.

Successful treatment of adult cerebral salt wasting with fludrocortisone

.

Arch Intern Med

.

2008

;

168

(

3

):

325

–

6

.

.

https://doi.org/10.1542/peds.2006-0702

40.

Taplin

CE

,

Cowell

CT

,

Silink

M

,

Ambler

GR

.

Fludrocortisone therapy in cerebral salt wasting

.

Pediatrics

.

2006

;

118

(

6

):

e1904

–

8

.

.

https://doi.org/10.1515/jpem.2007.20.10.1145

41.

Papadimitriou

DT

,

Spiteri

A

,

Pagnier

A

,

Bayle

M

,

Mischalowski

MB

,

Bourdat

G

, et al.

Mineralocorticoid deficiency in post-operative cerebral salt wasting

.

J Pediatr Endocrinol Metab

.

2007

;

20

(

10

):

1145

–

50

.

.

https://doi.org/10.1093/neuonc/nov044

42.

Sterkenburg

AS

,

Hoffmann

A

,

Gebhardt

U

,

Warmuth-Metz

M

,

Daubenbüchel

AM

,

Müller

HL

.

Survival, hypothalamic obesity, and neuropsychological/psychosocial status after childhood-onset craniopharyngioma: newly reported long-term outcomes

.

Neuro-oncology

.

2015

;

17

(

7

):

1029

–

38

.

.

https://doi.org/10.3238/arztebl.2019.0321

43.

Eveslage

M

,

Calaminus

G

,

Warmuth-Metz

M

,

Kortmann

RD

,

Pohl

F

,

Timmermann

B

, et al.

The postopera tive quality of life in children and adolescents with craniopharyngioma

.

Dtsch Arztebl Int

.

2019 May 3

;

116

(

18

):

321

–

8

.

.

https://doi.org/10.1111/j.1365-2265.2005.02231.x

44.

Karavitaki

N

,

Brufani

C

,

Warner

JT

,

Adams

CB

,

Richards

P

,

Ansorge

O

, et al.

Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up

.

Clin Endocrinol

.

2005

;

62

(

4

):

397

–

409

.

.

https://doi.org/10.1016/j.ijrobp.2014.01.019

45.

Lo

AC

,

Howard

AF

,

Nichol

A

,

Sidhu

K

,

Abdulsatar

F

,

Hasan

H

, et al.

Long-term outcomes and complications in patients with craniopharyngioma: the British Columbia Cancer Agency experience

.

Int J Radiat Oncol Biol Phys

.

2014

;

88

(

5

):

1011

–

8

.

.

https://doi.org/10.1007/s11060-010-0145-5

46.

Visser

J

,

Hukin

J

,

Sargent

M

,

Steinbok

P

,

Goddard

K

,

Fryer

C

.

Late mortality in pediatric patients with craniopharyngioma

.

J Neurooncol

.

2010

;

100

(

1

):

105

–

11

.

.

https://doi.org/10.3171/2010.11.JNS10670

47.

Mortini

P

,

Losa

M

,

Pozzobon

G

,

Barzaghi

R

,

Riva

M

,

Acerno

S

, et al.

Neurosurgical treatment of craniopharyngioma in adults and children: early and long-term results in a large case series

.

J Neurosurg

.

2011

;

114

(

5

):

1350

–

9

.

.

https://doi.org/10.3171/ped.2007.106.1.3

48.

Puget

S

,

Garnett

M

,

Wray

A

,

Grill

J

,

Habrand

JL

,

Bodaert

N

, et al.

Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement

.

J Neurosurg

.

2007

;

106

(

1 Suppl

):

3

–

12

.

.

49.

Grewal

MR

,

Spielman

DB

,

Safi

C

,

Overdevest

JB

,

Otten

M

,

Bruce

J

, et al.

Gross total versus subtotal surgical resection in the management of craniopharyngiomas

.

Allergy Rhinol

.

2020 Oct 29

;

11

:

1

–

6

.

https://doi.org/10.1530/EJE-18-0505

50.

Boekhoff

S

,

Bogusz

A

,

Sterkenburg

AS

,

Eveslage

M

,

Müller

HL

.

Long-term effects of growth hormone replacement therapy in childhood-onset craniopharyngioma: results of the German craniopharyngioma registry (HIT-Endo)

.

Eur J Endocrinol

.

2018

;

179

(

5

):

331

–

41

.

.

51.

Heinks

K

,

Boekhoff

S

,

Hoffmann

A

,

Warmuth-Metz

M

,

Eveslage

M

,

Peng

J

, et al.

Müller quality of life and growth after childhood craniopharyngioma: results of the multinational trial KRANIOPHARYNGEOM 2007

.

Endocrine

.

2018

;

59

:

364

–

72

.

52.

Darendeliler

F

,

Karagiannis

G

,

Wilton

P

,

Ranke

MB

,

Albertsson-Wikland

K

,

Anthony Price

D

.

On behalf of the kigs international B. Recurrence of brain tumours in patients treated with growth hormone: analysis of KIGS (Pfizer International Growth Database)

.

Acta Paediatrica

.

2006

;

95

:

1284

–

90

.

https://doi.org/10.1159/000023133

53.

Price

DA

,

Wilton

P

,

Jönsson

P

,

Albertsson-Wikland

K

,

Chatelain

P

,

Cutfield

W

, et al.

Efficacy and safety of growth hormone treatment in children with prior craniopharyngioma: an analysis of the Pharmacia and Upjohn International Growth Database (KIGS) from 1988 to 1996

.

Horm Res

.

1998

;

49

(

2

):

91

–

7

.

.

https://doi.org/10.1016/j.wneu.2017.09.164

54.

Alotaibi

NM

,

Noormohamed

N

,

Cote

DJ

,

Alharthi

S

,

Doucette

J

,

Zaidi

HA

, et al.

Physiologic growth hormone-replacement therapy and craniopharyngioma recurrence in pediatric patients: a meta-analysis

.

World Neurosurg

.

2018

;

109

:

487

–

e1

.

.

55.

Grimberg

A

,

DiVall

SA

,

Polychronakos

C

,

Allen

DB

,

Cohen

LE

,

Quintos

JB

, et al.

Guidelines for growth hormone and insulin-like growth factor-I treatment in children and adolescents: growth hormone deficiency, idiopathic short stature, and primary insulin-like growth factor-I deficiency

.

Horm Res Paediatr

.

2016

;

86

:

361

–

97

.

https://doi.org/10.1111/j.1365-2265.2004.02196.x

56.

Pereira

AM

,

Schmid

EM

,

Schutte

PJ

,

Voormolen

JH

,

Biermasz

NR

,

van Thiel

SW

, et al.

High prevalence of long-term cardiovascular, neurological and psychosocial morbidity after treatment for craniopharyngioma

.

Clin Endocrinol

.

2005

;

62

(

2

):

197

–

204

.

.

57.

Bulow

B

,

Attewell

R

,

Hagmar

L

,

Malmstrom

P

,

Nordstrom

CH

,

Erfurth

EM

.

Postoperative prognosis in craniopharyngioma with respect to cardiovascular mortality, survival, and tumor recurrence

.

J Clin Endocrinol Metab

.

1998

;

83

:

3897

–

904

.

https://doi.org/10.20945/2359-3997000000189

58.

van Bunderen

CC

,

Glad

C

,

Johannsson

G

,

Olsson

DS

.

Personalized approach to growth hormone replacement in adults

.

Arch Endocrinol Metab

.

2019 Nov-Dec

;

63

(

6

):

592

–

600

.

.

59.

Maison

P

,

Griffin

S

,

Nicoue-Beglah

M

,

Haddad

N

,

Balkau

B

,

Chanson

P

.

Metaanalysis of blinded, randomized, placebo-controlled trials. Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a metaanalysis of blinded, randomized, placebo-controlled trials

.

J Clin Endocrinol Metab

.

2004

;

89

:

2192

–

9

.

https://doi.org/10.1530/EJE-13-0280

60.

Yuen

KC

,

Koltowska-Häggström

M

,

Cook

DM

,

Fox

JL

,

Jönsson

PJ

,

Geffner

ME

, et al.

Clinical characteristics and effects of GH replacement therapy in adults with childhood-onset craniopharyngioma compared with those in adults with other causes of childhood-onset hypothalamic-pituitary dysfunction

.

Eur J Endocrinol

.

2013

;

169

(

4

):

511

–

9

.

.

https://doi.org/10.1530/EJE-09-0449

61.

Holmer

H

,

Ekman

B

,

Björk

J

,

Nordstöm

CH

,

Popovic

V

,

Siversson

A

, et al.

Hypothalamic involvement predicts cardiovascular risk in adults with childhood onset craniopharyngioma on long-term GH therapy

.

Eur J Endocrinol

.

2009

;

161

(

5

):

671

–

9

.

.

https://doi.org/10.1210/clinem/dgaa089

62.

Losa

M

,

Castellino

L

,

Pagnano

A

,

Rossini

A

,

Mortini

P

,

Lanzi

R

.

Growth hormone therapy does not increase the risk of craniopharyngioma and nonfunctioning pituitary adenoma recurrence

.

J Clin Endocrinol Metab

.

2020

;

105

(

5

):

dgaa089

.

.

https://doi.org/10.1210/jc.2014-3525

63.

Olsson

DS

,

Andersson

E

,

Bryngelsson

IL

,

Nilsson

AG

,

Johannsson

G

.

Excess mortality and morbidity in patients with craniopharyngioma, especially in patients with childhood onset: a population-based study in Sweden

.

J Clin Endocrinol Metab

.

2015

;

100

(

2

):

467

–

74

.

.

https://doi.org/10.1210/jcem.83.11.5240

64.

Bülow

B

,

Attewell

R

,

Hagmar

L

,

Malmström

P

,

Nordström

CH

,

Erfurth

EM

.

Postoperative prognosis in craniopharyngioma with respect to cardiovascular mortality, survival, and tumor recurrence

.

J Clin Endocrinol Metab

.

1998 Nov

;

83

(

11

):

3897

–

904

.

.

https://doi.org/10.1515/jpem-2014-0512

65.

Haliloglu

B

,

Bereket

A

.

Hypothalamic obesity in children: pathophysiology to clinical management

.

J Pediatr Endocrinol Metab

.

2015

;

28

(

5–6

):

503

–

13

.

.

https://doi.org/10.1007/s00431-008-0876-x

66.

Guran

T

,

Turan

S

,

Bereket

A

,

Akcay

T

,

Unluguzel

G

,

Bas

F

, et al.

The role of leptin, soluble leptin receptor, resistin, and insulin secretory dynamics in the pathogenesis of hypothalamic obesity in children

.

Eur J Pediatr

.

2009

;

168

(

9

):

1043

–

8

.

.

https://doi.org/10.1210/jc.2010-0993

67.

Holmer

H

,

Pozarek

G

,

Wirfält

E

,

Popovic

V

,

Ekman

B

,

Björk

J

, et al.

Reduced energy expenditure and impaired feeding-related signals but not high energy intake reinforces hypothalamic obesity in adults with childhood onset craniopharyngioma

.

J Clin Endocrinol Metab

.

2010 Dec

;

95

(

12

):

5395

–

402

.

.

https://doi.org/10.1055/s-2001-16855

68.

Müller

HL

,

Bueb

K

,

Bartels

U

,

Roth

C

,

Harz

K

,

Graf

N

, et al.

Obesity after childhood craniopharyngioma: German multicenter study on pre-operative risk factors and quality of life

.

Klin Padiatr

.

2001

;

213

(

4

):

244

–

9

.

.

https://doi.org/10.1210/jc.2003-031751

69.

Müller

HL

,

Emser

A

,

Faldum

A

,

Bruhnken

G

,

Etavard-Gorris

N

,

Gebhardt

U

, et al.

Longitudinal study on growth and body mass index before and after diagnosis of childhood craniopharyngioma

.

J Clin Endocrinol Metab

.

2004

;

89

(

7

):

3298

–

305

.

.

https://doi.org/10.1210/jc.2002-021180

70.

Lustig

RH

,

Post

SR

,

Srivannaboon

K

,

Rose

SR

,

Danish

RK

,

Burghen

GA

, et al.

Risk factors for the development of obesity in children surviving brain tumors

.

J Clin Endocrinol Metab

.

2003

;

88

(

2

):

611

–

6

.

.

https://doi.org/10.1002/oby.21067

71.

Roth

CL

,

Eslamy

H

,

Werny

D

,

Elfers

C

,

Shaffer

ML

,

Pihoker

C

, et al.

Semiquantitative analysis of hypothalamic damage on MRI predicts risk for hypothalamic obesity

.

Obesity

.

2015

;

23

(

6

):

1226

–

33

.

.

https://doi.org/10.1210/jc.2012-3928

72.

Elowe-Gruau

E

,

Beltrand

J

,

Brauner

R

,

Pinto

G

,

Samara-Boustani

D

,

Thalassinos

C

, et al.

Childhood craniopharyngioma: hypothalamus-sparing surgery decreases the risk of obesity

.

J Clin Endocrinol Metab

.

2013

;

98

(

6

):

2376

–

82

.

.

https://doi.org/10.1530/EC-19-0074

73.

Bogusz

A

,

Boekhoff

S

,

Warmuth-Metz

M

,

Calaminus

G

,

Eveslage

M

,

Müller

HL

.

Posterior hypothalamus-sparing surgery improves outcome after childhood craniopharyngioma

.

Endocr Connect

.

2019 May 1

;

8

(

5

):

481

–

92

.

.

https://doi.org/10.1111/j.1365-2265.2008.03284.x

74.

van der Klaauw

AA

,

Biermasz

NR

,

Pereira

AM

,

van Kralingen

KW

,

Dekkers

OM

,

Rabe

KF

, et al.

Patients cured from craniopharyngioma or nonfunctioning pituitary macroadenoma (NFMA) suffer similarly from increased daytime somnolence despite normal sleep patterns compared to healthy controls

.

Clin Endocrinol

.

2008

;

69

(

5

):

769

–

74

.

.

https://doi.org/10.1210/jc.2003-030442

75.

Srinivasan

S

,

Ogle

GD

,

Garnett

SP

,

Briody

JN

,

Lee

JW

,

Cowell

CT

.

Features of the metabolic syndrome after childhood craniopharyngioma

.

J Clin Endocrinol Metab

.

2004 Jan

;

89

(

1

):

81

–

6

.

.

https://doi.org/10.1111/ijpo.12076

76.

Haliloglu

B

,

Atay

Z

,

Guran

T

,

Abalı

S

,

Bas

S

,

Turan

S

, et al.

Risk factors for mortality caused by hypothalamic obesity in children with hypothalamic tumours

.

Pediatr Obes

.

2016

;

11

(

5

):

383

–

8

.

.

77.

Muller

HL

,

Handwerker

G

,

Wollny

B

,

Faldum

A

,

Sorensen

N

.

Melatonin secretion and increased daytime sleepiness in childhood craniopharyngioma patients

.

J Clin Endocrinol Metab

.

2002

;

87

:

3993

–

6

.

https://doi.org/10.1007/s11060-012-0859-7

78.

Manley

PE

,

McKendrick

K

,

McGillicudy

M

,

Chi

SN

,

Kieran

MW

,

Cohen

LE

, et al.

Sleep dysfunction in long term survivors of craniopharyngioma

.

J Neurooncol

.

2012

;

108

(

3

):

543

–

9

.

.

79.

Lustig

RH

.

Hypothalamic obesity: causes, consequences, treatment

.

Pediatr Endocrinol Rev

.

2008

;

6

(

2

):

220

–

7

.

https://doi.org/10.1016/j.pediatrneurol.2007.11.007

80.

Mong

S

,

Pomeroy

SL

,

Cecchin

F

,

Juraszek

A

,

Alexander

ME

.

Cardiac risk after craniopharyngioma therapy

.

Pediatr Neurol

.

2008

;

38

(

4

):

256

–

60

.

.

81.

Muller

HL

,

Handwerker

G

,

Gebhardt

U

,

Faldum

A

,

Emser

A

,

Kolb

R

, et al.

Melatonin treatment in obese patients with childhood craniopharyngioma and increased daytime sleepiness

.

Cancer Causes Control

.

2006

;

17

:

583

–

9

.

https://doi.org/10.1159/000496564

82.

Abuzzahab

MJ

,

Roth

CL

,

Shoemaker

AH

.

Hypothalamic obesity: prologue and promise

.

Horm Res Paediatr

.

2019

;

91

(

2

):

128

–

36

.

.

https://doi.org/10.1159/000495851

83.

Denzer

C

,

Denzer

F

,

Lennerz

BS

,

Vollbach

H

,

Lustig

RH

,

Wabitsch

M

.

Treatment of hypothalamic obesity with dextroamphetamine: a case series

.

Obes Facts

.

2019

;

12

(

1

):

91

–

102

.

.

https://doi.org/10.1210/jc.2002-030003

84.

Lustig

RH

,

Hinds

PS

,

Ringwald-Smith

K

,

Christensen

RK

,

Kaste

SC

,

Schreiber

RE

, et al.

Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial

.

J Clin Endocrinol Metab

.

2003

;

88

(

6

):

2586

–

92

.

.

https://doi.org/10.1155/2011/417949

85.

Hamilton

JK

,

Conwell

LS

,

Syme

C

,

Ahmet

A

,

Jeffery

A

,

Daneman

D

.

Hypothalamic obesity following craniopharyngioma surgery: results of a pilot trial of combined diazoxide and metformin therapy

.

Int J Pediatr Endocrinol

.

2011

;

2011

:

417949

.

.

86.

Vilsboll

T

,

Christensen

M

,

Junker

AE

,

Knop

FK

,

Gluud

LL

.

Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials

.

Br Med J

.

2012

;

344

:

d7771

.

https://doi.org/10.1530/EJE-12-0997

87.

Zoicas

F

,

Droste

M

,

Mayr

B

,

Buchfelder

M

,

Schöfl

C

.

GLP-1 analogues as a new treatment option for hypothalamic obesity in adults: report of nine cases

.

Eur J Endocrinol

.

2013

;

168

(

5

):

699

–

706

.

.

https://doi.org/10.1159/000339469

88.

Simmons

JH

,

Shoemaker

AH

,

Roth

CL

.

Treatment with glucagon-like peptide-1 agonist exendin-4 in a patient with hypothalamic obesity secondary to intracranial tumor

.

Horm Res Paediatr

.

2012

;

78

(

1

):

54

–

8

.

.

https://doi.org/10.1111/j.1365-2265.2012.04368.x

89.

Thondam

SK

,

Cuthbertson

DJ

,

Aditya

BS

,

Macfarlane

IA

,

Wilding

JP

,

Daousi

C

.

A glucagon-like peptide-1 (GLP-1) receptor agonist in the treatment for hypothalamic obesity complicated by type 2 diabetes mellitus

.

Clin Endocrinol

.

2012

;

77

(

4

):

635

–

7

.

.

https://doi.org/10.1002/oby.21493

90.

Lomenick

JP

,

Buchowski

MS

,

Shoemaker

AH

.

A 52-week pilot study of the effects of exenatide on body weight in patients with hypothalamic obesity

.

Obesity

.

2016

;

24

(

6

):

1222

–

5

.

.

https://doi.org/10.1210/jc.2017-02080

91.

Hsu

EA

,

Miller

JL

,

Perez

FA

,

Roth

CL

.

Oxytocin and naltrexone successfully treat hypothalamic obesity in a boy post-craniopharyngioma resection

.

J Clin Endocrinol Metab

.

2018

;

103

(

2

):

370

–

5

.

.

92.

Garrez

I

,

Lapauw

B

,

Van Nieuwenhove

Y

.

Bariatric surgery for treatment of hypothalamic obesity after craniopharyngioma. Therapy: a matched case-control study

.

Obes Surg

.

2020

;

30

:

2439

–

44

.

https://doi.org/10.1055/s-2007-985848

93.

Müller

HL

,

Gebhardt

U

,

Wessel

V

,

Schröder

S

,

Kolb

R

,

Sörensen

N

, et al.

First experiences with laparoscopic adjustable gastric banding (LAGB) in the treatment of patients with childhood craniopharyngioma and morbid obesity

.

Klin Padiatr

.

2007

;

219

(

6

):

323

–

5

.

.

https://doi.org/10.1530/EJE-09-0079

94.

Schultes

B

,

Ernst

B

,

Schmid

F

,

Thurnheer

M

.

Distal gastric bypass surgery for the treatment of hypothalamic obesity after childhood craniopharyngioma

.

Eur J Endocrinol

.

2009

;

161

(

1

):

201

–

6

.

.

https://doi.org/10.1038/ncpendmet0579

95.

Inge

TH

,

Pfluger

P

,

Zeller

M

,

Rose

SR

,

Burget

L

,

Sundararajan

S

, et al.

Gastric bypass surgery for treatment of hypothalamic obesity after craniopharyngioma therapy

.

Nat Clin Pract Endocrinol Metab

.

2007

;

3

(

8

):

606

–

9

.

.

https://doi.org/10.17458/per.vol14.2017.SBP.FD.Bariatric

96.

Stolbova

S

,

Benes

M

,

Petruzelkova

L

,

Lebl

J

,

Kolouskova

S

.

For debate: should bariatric surgery be performed in children and adolescents with hypothalamic obesity?

Pediatr Endocrinol Rev

.

2017

;

14

(

4

):

348

–

52

.

.

https://doi.org/10.1016/j.sempedsurg.2020.150890

97.

Pratt

JSA

,

Roque

SS

,

Valera

R

,

Czepiel

KS

,

Tsao

DD

,

Stanford

FC

.

Preoperative considerations for the pediatric patient undergoing metabolic and bariatric surgery

.

Semin Pediatr Surg

.

2020

;

29

(

1

):

150890

.

.

https://doi.org/10.1210/jc.2012-4184

98.

Bretault

M

,

Boillot

A

,

Muzard

L

,

Poitou

C

,

Oppert

JM

,

Barsamian

C

, et al.

Clinical review: bariatric surgery following treatment for craniopharyngioma: a systematic review and individual-level data meta-analysis

.

J Clin Endocrinol Metab

.

2013 Jun

;

98

(

6

):

2239

–

46

.

.

https://doi.org/10.1016/s0140-6736(83)92437-6

99.

Smith

DK

,

Sarfeh

J

,

Howard

L

.

Truncal vagotomy in hypothalamic obesity

.

Lancet

.

1983

;

1

(

8337

):

1330

–

1

.

.

100.

Prologo

JD

,

Lin

E

,

Horesh Bergquist

S

,

Knight

J

,

Matta

H

,

Brummer

M

, et al.

Percutaneous CT-guided cryovagotomy in patients with class I or class II obesity: a pilot trial

.

Obesity

.

2019

;

27

:

1255

–

65

.

https://doi.org/10.1007/s00381-012-1926-2

101.

Clark

AJ

,

Cage

TA

,

Aranda

D

,

Parsa

AT

,

Sun

PP

,

Auguste

KI

, et al.

A systematic review of the results of surgery and radiotherapy on tumor control for pediatric craniopharyngioma

.

Childs Nerv Syst

.

2013

;

29

(

2

):

231

–

8

.

.

https://doi.org/10.3171/2017.10.PEDS17254

102.

Yamada

S

,

Fukuhara

N

,

Yamaguchi-Okada

M

,

Nishioka

H

,

Takeshita

A

,

Takeuchi

Y

, et al.

Therapeutic outcomes of transsphenoidal surgery in pediatric patients with craniopharyngiomas: a single-center study

.

J Neurosurg Pediatr

.

2018

;

21

(

6

):

549

–

62

.

.

https://doi.org/10.1210/jc.2019-01299

103.

Alexandraki

KI

,

Kaltsas

GA

,

Karavitaki

N

,

Grossman

AB

.

The medical therapy of craniopharyngiomas: the way ahead

.

J Clin Endocrinol Metab

.

2019

;

104

(

12

):

5751

–

64

.

.